Literature DB >> 33505429

Whole-Exome Sequencing Uncovers Novel Causative Variants and Additional Findings in Three Patients Affected by Glycogen Storage Disease Type VI and Fanconi-Bickel Syndrome.

Maryam Eghbali1, Kiyana Sadat Fatemi2, Shadab Salehpour3,4, Maryam Abiri5,6, Hassan Saei6, Saeed Talebi6, Nasrin Alipour Olyaei3, Vahid Reza Yassaee3, Mohammad Hossein Modarressi1.   

Abstract

Glycogen storage diseases (GSDs) are the heterogeneous group of disorders caused by mutations in at least 30 different genes. Different types of GSDs, especially liver GSDs, take overlapping symptoms and can be clinically indistinguishable. This survey evaluated the use of whole-exome sequencing (WES) for the genetic analysis of the liver GSD-suspected patients in three unrelated families. An in-house filtering pipeline was used to assess rare pathogenic variants in GSD-associated genes, autosomal recessive/mendelian disorder genes (carrier status for genetic counseling subjects), and the ACMG's list of 59 actionable genes. For the interpretation of the causative variants and the incidental/secondary findings, ACMG guidelines were applied. Additionally, we have explored PharmGKB class IA/IB pharmacogenetic variants. The segregation analysis was performed using Sanger sequencing for the novel causative variants. Bioinformatics analysis of the exome data in three individuals revealed three novel homozygous causative variants in the GSD-associated genes. The first variant, c.298_307delATGATCAACC in PYGL gene has related to HERS disease (GSD VI). Both variants of c.1043dupT and c.613-1G > C in SLC2A2 gene have been associated with Fanconi-Bickel syndrome (GSDXI). Eight pathogenic/likely pathogenic medical actionable findings in Mendelian disease genes and 10 pharmacogenetic variants with underlying drug response phenotypes have been identified. No known/expected pathogenic variants were detected in the ACMG's list of 59 actionable genes. The logical filtering steps can help in finding other medical actionable secondary/incidental findings as well as effectively identifying the causative variants in heterogeneous conditions such as GSDs. Three novel variants related to GSD genes recognized in liver GSD-suspected patients with early infantile and childhood-age onset.
Copyright © 2021 Eghbali, Fatemi, Salehpour, Abiri, Saei, Talebi, Olyaei, Yassaee and Modarressi.

Entities:  

Keywords:  glycogen storage diseases; novel causative variants; pharmacogenetic variants; secondary/incidental findings; whole-exome sequencing

Year:  2021        PMID: 33505429      PMCID: PMC7831547          DOI: 10.3389/fgene.2020.601566

Source DB:  PubMed          Journal:  Front Genet        ISSN: 1664-8021            Impact factor:   4.599


  39 in total

Review 1.  Genomic medicine--a primer.

Authors:  Alan E Guttmacher; Francis S Collins
Journal:  N Engl J Med       Date:  2002-11-07       Impact factor: 91.245

2.  SIFT missense predictions for genomes.

Authors:  Robert Vaser; Swarnaseetha Adusumalli; Sim Ngak Leng; Mile Sikic; Pauline C Ng
Journal:  Nat Protoc       Date:  2015-12-03       Impact factor: 13.491

3.  Mutations in the liver glycogen phosphorylase gene (PYGL) underlying glycogenosis type VI.

Authors:  B Burwinkel; H D Bakker; E Herschkovitz; S W Moses; Y S Shin; M W Kilimann
Journal:  Am J Hum Genet       Date:  1998-04       Impact factor: 11.025

4.  The natural history of glycogen storage disease types VI and IX: Long-term outcome from the largest metabolic center in Canada.

Authors:  Anne Roscher; Jaina Patel; Stacy Hewson; Laura Nagy; Annette Feigenbaum; Jonathan Kronick; Julian Raiman; Andreas Schulze; Komudi Siriwardena; Saadet Mercimek-Mahmutoglu
Journal:  Mol Genet Metab       Date:  2014-09-21       Impact factor: 4.797

5.  The influence of sequence variations in factor VII, gamma-glutamyl carboxylase and vitamin K epoxide reductase complex genes on warfarin dose requirement.

Authors:  Darja Herman; Polona Peternel; Mojca Stegnar; Katja Breskvar; Vita Dolzan
Journal:  Thromb Haemost       Date:  2006-05       Impact factor: 5.249

6.  The Sequence Alignment/Map format and SAMtools.

Authors:  Heng Li; Bob Handsaker; Alec Wysoker; Tim Fennell; Jue Ruan; Nils Homer; Gabor Marth; Goncalo Abecasis; Richard Durbin
Journal:  Bioinformatics       Date:  2009-06-08       Impact factor: 6.937

7.  VKORC1 pharmacogenomics summary.

Authors:  Ryan P Owen; Li Gong; Hersh Sagreiya; Teri E Klein; Russ B Altman
Journal:  Pharmacogenet Genomics       Date:  2010-10       Impact factor: 2.089

8.  Predicting functional effect of human missense mutations using PolyPhen-2.

Authors:  Ivan Adzhubei; Daniel M Jordan; Shamil R Sunyaev
Journal:  Curr Protoc Hum Genet       Date:  2013-01

9.  Diagnosis and management of glycogen storage disease type I: a practice guideline of the American College of Medical Genetics and Genomics.

Authors:  Priya S Kishnani; Stephanie L Austin; Jose E Abdenur; Pamela Arn; Deeksha S Bali; Anne Boney; Wendy K Chung; Aditi I Dagli; David Dale; Dwight Koeberl; Michael J Somers; Stephanie Burns Wechsler; David A Weinstein; Joseph I Wolfsdorf; Michael S Watson
Journal:  Genet Med       Date:  2014-11       Impact factor: 8.822

10.  VarSome: the human genomic variant search engine.

Authors:  Christos Kopanos; Vasilis Tsiolkas; Alexandros Kouris; Charles E Chapple; Monica Albarca Aguilera; Richard Meyer; Andreas Massouras
Journal:  Bioinformatics       Date:  2019-06-01       Impact factor: 6.937

View more
  4 in total

1.  Case Report: Fanconi-Bickel Syndrome in a Chinese Girl With Diabetes and Severe Hypokalemia.

Authors:  Hongbo Chen; Juan-Juan Lyu; Zhuo Huang; Xiao-Mei Sun; Ying Liu; Chuan-Jie Yuan; Li Ye; Dan Yu; Jin Wu
Journal:  Front Pediatr       Date:  2022-06-09       Impact factor: 3.569

2.  Understanding the Mechanism of Dysglycemia in a Fanconi-Bickel Syndrome Patient.

Authors:  Sanaa Sharari; Mustapha Aouida; Idris Mohammed; Basma Haris; Ajaz Ahmad Bhat; Iman Hawari; Sabah Nisar; Igor Pavlovski; Kabir H Biswas; Najeeb Syed; Selma Maacha; Jean-Charles Grivel; Maryam Saifaldeen; Johan Ericsson; Khalid Hussain
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-18       Impact factor: 6.055

Review 3.  Hypoglycaemia Metabolic Gene Panel Testing.

Authors:  Arianna Maiorana; Francesca Romana Lepri; Antonio Novelli; Carlo Dionisi-Vici
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-29       Impact factor: 5.555

4.  Genotypic and phenotypic characteristics of 12 chinese children with glycogen storage diseases.

Authors:  Rui Dong; Xuxia Wei; Kaihui Zhang; Fengling Song; Yuqiang Lv; Min Gao; Dong Wang; Jian Ma; Zhongtao Gai; Yi Liu
Journal:  Front Genet       Date:  2022-08-29       Impact factor: 4.772

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.